On May 17, 2022, the U.S. District Court for the District of Columbia ruled in favor of the plaintiff pharmaceutical manufacturer trade group in Pharmaceutical Research and
Manufacturers of America (“PhRMA”) vs. Becerra in its challenge of the accumulator adjustment rule issued by the Center for Medicare & Medicaid Services in 2020 and set to take effect on January 1, 2023.